TransMedics Group Inc (TMDX)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 37,496 31,455 -803 -14,217 -28,727 -38,109 -15,318 -24,157 -31,437 -35,986 -42,167 -42,290 -39,428 -33,996 -26,881 -24,874 -26,384 -29,182 -31,814 -31,658
Revenue (ttm) US$ in thousands 441,540 401,090 358,759 296,919 241,623 191,824 151,077 119,133 93,459 71,752 51,439 39,089 30,262 28,221 29,942 25,162 25,639 24,069 24,183 26,458
Operating profit margin 8.49% 7.84% -0.22% -4.79% -11.89% -19.87% -10.14% -20.28% -33.64% -50.15% -81.97% -108.19% -130.29% -120.46% -89.78% -98.86% -102.91% -121.24% -131.56% -119.65%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $37,496K ÷ $441,540K
= 8.49%

TransMedics Group Inc's operating profit margin experienced a prolonged period of negative margins from March 2020 to June 2022, indicating that the company was incurring operating losses during this time. However, there was a notable turnaround starting from September 2022, with the operating profit margin shifting to positive territory. This improvement continued into 2024, with the operating profit margin showing consistent growth, reaching 8.49% by December 31, 2024. This positive trend suggests that TransMedics Group Inc was able to enhance its operational efficiency and profitability over the analyzed period.


Peer comparison

Dec 31, 2024